(Q45082419)

9 December 2017

title

Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone (English)

1 reference

9 December 2017

1 reference

D. F. Archer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7645623

11 July 2024

G. E. Fahy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7645623

11 July 2024

A. Viniegra-Sibal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7645623

11 July 2024

F. D. Anderson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7645623

11 July 2024

W. Snipes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7645623

11 July 2024

R. G. Foldesy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7645623

11 July 2024

language of work or name

English

0 references

publication date

1 August 1995

1 reference

full work available at URL

9 December 2017

https://api.elsevier.com/content/article/PII:0002937895902686?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

https://api.elsevier.com/content/article/PII:0002937895902686?httpAccept=text/plain

11 July 2024

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

American Journal of Obstetrics and Gynecology

11 July 2024

published in

1 reference

9 December 2017

volume

173

1 reference

9 December 2017

issue

2

1 reference

9 December 2017

page(s)

471-7; discussion 477-8

1 reference

Absorption and metabolism of oral progesterone.

9 December 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure

11 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

The window of embryo transfer and the efficiency of human conception in vitro.

11 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Vaginal Progesterone for Contraception

11 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of a progesterone-releasing vaginal ring

11 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

New developments in oral, injectable and implantable contraceptives, vaginal rings and intrauterine devices. A review

11 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Progesterone-releasing vaginal rings for use in postpartum contraception. I. In vitro release rates of progesterone from core-loaded rings

11 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Progesterone-releasing vaginal rings for use in postpartum contraception. II. Pharmacokinetic profiles in women

11 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone

11 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Comparative bioavailability of orally and vaginally administered progesterone

11 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Bioavailability of progesterone with different modes of administration

11 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Sedative and hypnotic effects of oral administration of micronized progesterone may be mediated through its metabolites.

11 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Comparison of serum progesterone levels in dogs after administration of progesterone by vaginal tablet and vaginal suppositories

11 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Intravaginal administration of progesterone: enhanced absorption after estrogen treatment**Supported by Rockefeller Foundation Grant RF-75029

11 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone*†*Supported in part by a grant from Besins-Iscovesco, Paris, France.†Presented in part at the 35th Annual Mee

11 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.

11 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Pregnancies following ovum donation in gonadal dysgenesis

11 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Effects of vehicle supplementation on total estradiol absorption from a transdermal estradiol delivery system

11 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.

11 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone

11 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/0002-9378(95)90268-6

11 July 2024

Identifiers

1 reference

9 December 2017

1 reference